We are committed to allocating 2.5 percent of GDP to Health: Nadda

Published On 2019-02-08 11:12 GMT   |   Update On 2019-02-08 11:12 GMT


New Delhi: "I am happy to share that the country has set an example globally by increasing its domestic financial allocations for health. India stands committed to increasing its overall health allocations to 2.5% of its GDP as enunciated in the National Health Policy, 2017.” This was stated by Shri J P Nadda, Union Minister of Health and Family Welfare during his address at the inauguration of ‘India Showcase Event’ as part of the Preparatory Meeting of the Sixth Global Fund Replenishment, here today.

Shri Nadda said that this milestone meeting is in tandem with the vision of the Hon'ble Prime Minister who has given the clarion call to eliminate HIV/AIDS, TB and Malaria. “Under his guidance, we have continued our impactful strategies alongside path-breaking innovations to ensure high-impact programmes that improve health indicators and other determinants of wellness,” Shri Nadda emphasized.


The Union Health Minister further said that India is prioritising resource allocations for Tuberculosis with more than 2 billion USD, being invested in the implementation of the National Strategic Plan to End TB 2017-2025. “This amount is separate from the additional amount of 100 million USD, being invested for nutritional support to TB patients under the NikshayPoshanYojna.As resolved by the Hon’ble Prime Minister at the End TB Summit, 2018 in New Delhi, the country is galvanising all efforts to End TB by 2025, five years ahead of the SDG target,” Shri Nadda added.


Shri Nadda said that the Health Ministry is working to ensure smooth and sustained coordination among different departments and ministries to ensure a convergence of efforts to End TB by 2025. “This inter-sectoral and multi-stakeholder approach has already demonstrated positive results on TB notifications in several states,” he said.


Shri Nadda also highlighted the initiatives and achievements of the Government in HIV/AIDS and Malaria. He stated that the country has launched the National Strategic Plan on HIV/AIDS and Sexually Transmitted Infections (STI), 2017-24. “By 2024, the target is to ensure that 95% of HIV positive people in the country know their status, 95% of those who know their status are on treatment and 95% of those who are on treatment experience effective viral load suppression. Steps have been taken to ensure that there is no shortage of funds, drugs and testing kits,” he elaborated.


He further said that the WHO world malaria report singled out India for its impressive gains against malaria. “Among the high burden countries, only India showed a substantial decline in disease burden, with a 24% drop in cases. India is on course to meet the goal of ending malaria by 2030,” he said.


The Union Health Minister said that PM Jan AarogyaYojana (PMJAY), a National Health Protection Scheme, which envisions health assurance of Rs. 5 lakhs per family per year, benefiting over 50crore people. “I am happy to share that since the roll-out of ‘Modicare’, in merely 135 days nearly 1.1 million people have already availed of the benefits worth RS. 15 Billion under the scheme,” he added.


Shri Ashwini Kumar Choubey, Minister of State for Health and Family Welfare, reiterated the Government’s commitment to making India free of TB, Malaria and HIV/AIDS. He emphasized on enhancing people’s awareness and people’s participation in eliminating them. He further stated that this platform will give an opportunity to share innovations that India has introduced on Health and specifically on HIV/AIDS, TB and Malaria. “By hosting this meeting, we exhibit the country’s commitment and political will to fight these diseases,” he added.


Shri Ashwini Kumar Choubey, Minister of State (HFW), Dr. Vinod K Paul, Member, NITI Aayog, SmtPreeti Sudan, Secretary (Health), Dr. Soumya Swaminathan, Deputy Director General of Programmes, WHO, Mr. Peter Sands, Executive Director, The Global Fund and Dr. Bilali Camara, Country Director, UNAIDS and delegations and representatives from several countries were also present.


Dr V K Paul, Member, NITI Aayog, stated that India has made a paradigm shift in health systems strengthening through systems-level changes and said that there is an urgent need to continue investing in systems along with new research and innovation.


Mr Peter Sands, Executive Director of the Global Fund, stated that the Global Fund is honoured by India’s hosting of the Preparatory Meeting of the Global Fund’s Sixth Replenishment. It demonstrates India’s strong commitment to fighting the diseases in India, and its leadership in global health.


India is in a sustained partnership with the Global Fund to fight against AIDS, Tuberculosis and Malaria (GFATM) since 2002 as the recipient as well as the donor. The Global Fund support has been instrumental in attaining targets related to HIV/AIDS, TB and Malaria reduction and escalating the fight against these three diseases. The Global Fund raises funds in multiyear cycles known as Replenishments and is preparing for sixth voluntary replenishment conference to mobilize needed resources to scale up life-saving programs over 2020-22.


A high-level preparatory meeting for the sixth replenishment conference of the Global Fund is being hosted by India on 7th -8th February 2019 in New Delhi. The preparatory meeting will set the stage for the Global Fund to launch its investment case for its sixth replenishment conference and its fund mobilization campaign.


India is the first implementing country to host a replenishment milestone, which presents an unprecedented and unique opportunity to highlight India’s role and political leadership in global health, as well as its strong commitment to achieving SDG3.


The Ministry of Health and Family Welfare is organizing “India Showcase” to highlight India’s global footprint in the field of innovation and technology to end AIDS, tuberculosis and malaria and its increased ownership of the national response and its growing role in development.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News